Arcutis Biotherapeutics Inc Cash Flow Statement

ARQT $27.74 0.8 3.1%

7:24pm

Highly Speculative, Mid Cap, Sucker Stock

Market Cap £794.4m

Enterprise Value £830.9m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock Arcutis Biotherapeutics Inc's cashflow statement please upgrade your membership.

	2017	2018
Period End:	2017-12-31	2018-12-31
Period Length:	12M	12M
Currency:	USD	USD

Net Income/Starting Line

Non-Cash Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital
Prepaid Expenses
Accounts Payable
Accrued Expenses
Cash from Operating Activities

Other Investing Cash Flow Items, Total
Purchase of Investments
Cash from Investing Activities

Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.